Medicare’s New Bridge Program for GLP-1s

June 22, 2026

Medicare Part D to Cover GLP-1s for Weight Loss


A significant shift in Medicare drug coverage is underway. Starting July 1, 2026, the Medicare GLP-1 Bridge program will temporarily allow coverage of certain weight-loss medications — including Wegovy, Zepbound (KwikPen formulation), and Foundayo — for eligible Medicare Part D beneficiaries.


For many seniors who have struggled with the high cost of these medications, this pilot program represents one of the most notable changes to Medicare prescription coverage in years.



Why This Program Matters


Historically, Medicare has been prohibited by law from covering drugs prescribed specifically for weight loss. That long-standing restriction has put GLP-1 medications financially out of reach for many beneficiaries, with cash prices that can range from roughly $150 to nearly $700 per month, depending on the drug and dosage.


The Bridge program is designed to fill that coverage gap on a short-term basis while the Centers for Medicare & Medicaid Services (CMS) studies whether broader access could improve long-term health outcomes.



How the Bridge Program Works


The Medicare GLP-1 Bridge will run from July 1, 2026, through December 31, 2027. Here's a quick overview:


  • Covered medications (as of June, 2026): Wegovy (injection and tablets), the KwikPen formulation of Zepbound, and Foundayo
  • Monthly copay: A flat $50 per prescription, regardless of dosage
  • Eligibility requirement: Enrollment in a Medicare Part D standalone plan or a Medicare Advantage plan with drug coverage (MA-PD). See the next section for additional eligibility criteria.
  • Prior authorization: Required, submitted by your prescribing provider
  • Processing: Handled through a centralized CMS system rather than individual Part D plans


Because the program operates outside the standard Part D benefit, prescribers and pharmacies will route claims through a central processor designated by CMS.



Who May Be Eligible


Eligibility is based on body mass index (BMI) and related health conditions. According to CMS, a beneficiary must be at least 18 years old and fall into one of these clinical categories at the time GLP-1 therapy is initiated:


  • BMI of 35 or higher (no additional condition required); or
  • BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension, or chronic kidney disease (stage 3a or higher); or
  • BMI of 27 or higher, plus a diagnosis of pre-diabetes, previous heart attack, previous stroke, or symptomatic peripheral artery disease


The medication must also be prescribed alongside structured lifestyle modifications, including nutrition and physical activity guidance consistent with FDA-approved labeling.


It's important to note that beneficiaries already taking GLP-1 drugs for Medicare-covered health conditions such as Type 2 diabetes or certain cardiovascular indications will continue to access those medications through their existing Part D plan. The Bridge program is specifically for weight-loss prescriptions.



A Quick Look at GLP-1 Medications


This class of drugs, GLP-1 receptor agonists, mimic a hormone that helps regulate blood sugar and appetite. They slow digestion, help people feel full longer, and may support meaningful weight reduction when combined with lifestyle changes.


For beneficiaries with weight-related health concerns, sustained weight loss may help with:


  • Heart disease
  • High blood pressure
  • Type 2 diabetes
  • Sleep apnea
  • Joint problems


As with any medication, GLP-1 drugs carry potential side effects and aren't right for everyone. Conversations with a qualified provider are essential.



Important Limitations to Understand


While the Bridge program offers significant savings, there are a few notable trade-offs:


  • The $50 copay does not count toward the Part D deductible or the annual out-of-pocket prescription drug spending cap
  • Part D low-income subsidies (Extra Help) cannot be applied to these prescriptions
  • The program is temporary (for now), ending December 31, 2027
  • Studies suggest many people regain weight after stopping GLP-1 therapy, which raises important planning considerations once the program concludes



What Happens After 2027


CMS originally designed the Bridge as a transition to a longer-term initiative called the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth). However, the timeline and structure of that model are still evolving, and ongoing access to GLP-1s for weight loss beyond 2027 is not yet guaranteed.


Beneficiaries who benefit from the Bridge program will want to review their drug plan options carefully during future Annual Enrollment Periods to understand what coverage may be available.



Recap


The Medicare GLP-1 Bridge represents a temporary, targeted opportunity for eligible Part D beneficiaries to access weight-loss medications at a more predictable cost. Like any pilot program, the details may continue to evolve as CMS releases additional guidance.


If you think you may qualify, the best first step is a conversation with your health care provider about whether a GLP-1 medication fits your overall health picture. For program specifics, visit CMS.gov or Medicare.gov, or call 1-800-MEDICARE (1-800-633-4227).

Person talking to someone off-screen beside a laptop on a desk, in a home office.
July 23, 2026
Open enrollment for 2027 ACA coverage ends earlier, and the February start date is going away. Find the currently-known national schedule and your state's timelines here.
Four people collaborate around a laptop and papers at a table in a bright office workspace.
July 15, 2026
Help your employees choose the right health insurance plan. Learn the 6 most common open enrollment mistakes and how employers can help avoid them.
Person lying on a gray sofa under a teal blanket in a cozy living room.
July 8, 2026
GLP-1 medications like Ozempic, Wegovy and Zepbound help you eat less — but eating less can mean fewer nutrients. Here's what the latest research shows and how to eat well.
Young child in a yellow dress smiling in a bright clinic with a masked adult in the background
July 6, 2026
If you have a high-deductible health plan and no HSA, you're paying more in taxes than you need to. Here's how a Health Savings Account works and why starting early makes a big difference.
Two sparklers burning with bright white sparks against a warm orange background
June 29, 2026
Learn simple Fourth of July safety tips to help prevent injuries, fires, and accidents while enjoying fireworks and holiday celebrations. 
A bent dollar bill with a bandage across the center, lying on a beige surface.
June 29, 2026
The Health Plan Cost-Reduction Opportunities That Are Flying Under Your Radar Premium hikes get all the attention. But for many employers, the bigger cost problems a re hiding in plain sight. They're embedded in gaps your current plan may not be addressing at all, and year after year they quietly add up. Here are three areas worth a closer look. Addiction Support Services Behavioral health, and particularly substance use disorders, remains one of the most expensive and least efficiently managed areas of employer-sponsored health care. Untreated mental health and addiction issues contribute to higher medical claims, absenteeism, and lost productivity. According to the Center for Prevention and Health Services, untreated mental health concerns can cost a single organization tens of thousands of dollars annually and amount to more than $100 billion nationwide. Despite those figures, addiction and recovery services have historically received less attention than other wellness initiatives. Inpatient treatment models can be disruptive for employees and expensive for employers, while high relapse rates have made some organizations hesitant to invest more heavily in this space. But that hesitation has a price tag that shouldn't be ignored. Employer opportunity: More employers are moving toward structured recovery programs that emphasize ongoing support, medication-assisted treatment, and measurable outcomes. It's a shift from one-time intervention toward sustained accountability, and early results are promising. Improving Access to Specialty Care Employees may technically have coverage, but long wait times for specialists can delay treatment and worsen underlying conditions. Nationally, more than 100 million specialty referrals are issued each year, yet patients in many metropolitan areas wait more than a month to see specialists such as gastroenterologists, dermatologists, or cardiologists. When employees cannot access specialty care in a timely manner, they are more likely to rely on emergency rooms or urgent care, which drives up costs. Employer opportunities: Some employers are responding by supplementing traditional plans with specialty telehealth solutions or third-party platforms that shorten wait times and improve care coordination. Before adding anything, it's worth surveying your employees directly. You may find the gaps are more specific, or more serious, than you expected. This allows you to target the most impactful solutions. Using Your Own Data Most employers have more information about their workforce's health patterns than they realize, but many just aren't using it. Carrier-provided dashboards, health risk assessments, and plan modeling tools can show you where utilization is running high, where employees aren't engaging with available programs, and where cost trends are moving in the wrong direction. Employer opportunities: Reviewing claims data quarterly, rather than annually, gives you a much clearer picture of what's working and what isn't. Understanding which programs are being under-utilized can show you where you have education opportunities with your workforce. Closely assessing usage data for all areas of your benefits package can allow an employer to spot waste, redirect spending, and build a benefits package that actually reflects how employees use their coverage rather than relying on theoretical models. You can also quickly spot which interventions are producing results and which benefits areas are at risk. That kind of visibility allows organizations to refine benefits with greater precision and financial discipline. A Practical Starting Point Rising health care costs aren't going away anytime soon, but understanding where the less obvious cost drivers are gives you a better chance of addressing them. Start by auditing what data you already have access to. Work with your broker to find solutions to specialty access gaps in your area. And take an honest look at how your current plan handles behavioral health and addiction support. Small adjustments in these elements of your health plan can have a real impact on the people who are depending on your plan, and on your bottom line.
Two smiling women hugging outdoors, one in a red sweater and the other in a navy floral top.
June 22, 2026
June is Alzheimer's & Brain Awareness Month. Learn how Medicare supports cognitive health with wellness visits, dementia care planning, and caregiver resources.
A group of four seniors walk near a hotel on a sunny day with palm trees in the background.
By Agency Bloc March 11, 2026
Get ready for your summer vacation with these 7 smart travel health tips. Learn what Medicare and private insurance cover, and how to avoid costly surprises while away.
A doctor consults with a patient over video.
By Agency Bloc March 11, 2026
Explore the benefits of telehealth for Medicare beneficiaries and individuals under 65. From virtual urgent care to mental health services, learn how telehealth improves access, affordability, and convenience.
Show More